Apollo Hospitals Strong Q2 FY26 Performance Driven by Healthcare Services

Apollo Hospitals Enterprise Limited announced a strong financial performance for Q2 FY26. Consolidated Revenue grew by 13% to ₹63,035 million, and EBITDA increased by 15% to ₹9,412 million. The PAT grew by 26% to ₹4,772 million. Healthcare Services drove much of the revenue, backed by outpatient and inpatient volume increases. Digital health initiatives and pharmacy distribution also contributed significantly to overall growth.

Q2 FY26 Financial Highlights

Apollo Hospitals Enterprise Limited reported robust financial results for Q2 FY26, demonstrating growth across key performance indicators:

  • Consolidated Revenue: ₹63,035 million (up 13% year-over-year)
  • EBITDA: ₹9,412 million (up 15% year-over-year)
  • PAT: ₹4,772 million (up 26% year-over-year)

Segment Performance

Healthcare Services

The Healthcare Services segment continues to be a major revenue generator. Key metrics include:

  • Revenue: ₹31,690 million, a 9% increase year-over-year.
  • EBITDA Margin: 24.6%
  • Inpatient volume increased by 2%.

Apollo HealthCo

This segment includes offline and online pharmacy distribution, showing substantial growth. Highlights include:

  • Total Revenue: ₹26,606 million, representing a 17% year-over-year increase.
  • Offline Pharmacy Distribution Revenue: ₹23,347 million (up 16% year-over-year).
  • Online Pharmacy Distribution Revenue: ₹3,259 million (up 22% year-over-year).

Diagnostics and Retail Health (AHLL)

The Diagnostics and Retail Health segment continues to expand its reach and services:

  • Revenue: ₹4,739 million, up 17% year-over-year.
  • Expansion includes new clinics and dialysis centers.

Expansion Plans

Apollo Hospitals plans to add approximately 3,600 census beds over the next five years, targeting a total of approximately 13,100 beds post-expansion.

Digital Health and Telehealth

The Apollo 24|7 platform reported 44 million registered users. Omni-channel strategies, including virtual doctor consultations and online medicine delivery, continue to drive customer engagement. They report serving ~1 million transactions every day.

Source: BSE

Previous Article

Route Mobile Monitoring Agency Report for Quarter Ended September 30, 2025

Next Article

Alivus Life Sciences Strong Q2FY26 Revenue Growth of 16% YoY

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *